These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6248082)

  • 1. Summary of safety tests with pipecurium bromide, a new neuromuscular blocking agent.
    Cholnoky E
    Arzneimittelforschung; 1980; 30(2a):370-4. PubMed ID: 6248082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of pipecurium bromide in rats.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First clinical experience with a new neuromuscular blocker pipecurium bromide.
    Alánt O; Darvas K; Pulay I; Weltner J; Bihari I
    Arzneimittelforschung; 1980; 30(2a):374-9. PubMed ID: 6248083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with a new steroid muscle relaxant: pipecurium bromide.
    Bunjatjan AA; Miheev VI
    Arzneimittelforschung; 1980; 30(2a):383-5. PubMed ID: 6248085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z
    Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.
    Tassonyi E; Szabó G; Vereczkey L
    Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on clinical test of pipecurium bromide.
    Wittek L; Gecsényi M; Barna B; Hargitay Z; Adorján K
    Arzneimittelforschung; 1980; 30(2a):379-83. PubMed ID: 6248084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical study of pipecurium bromide and pancuronium bromide.
    Boros M; Szenohradszky J; Marosi G; Tóth I
    Arzneimittelforschung; 1980; 30(2a):389-93. PubMed ID: 6248087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
    Barankay A
    Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the steroid muscle relaxant pipecurium bromide on the acetylcholinesterase activity of red blood cells in vitro.
    Simon G; Biró K; Kárpáti E; Tuba Z
    Arzneimittelforschung; 1980; 30(2a):360-3. PubMed ID: 6248079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On some properties of a new steroid curare-like compound pipecurium bromide.
    Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA
    Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2 beta,16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha,17 beta-diacetoxy-5 alpha-androstane dibromide and related compounds.
    Tuba Z
    Arzneimittelforschung; 1980; 30(2a):342-6. PubMed ID: 6248076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)].
    Tuba Z; Mahó S
    Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum.
    Szabó G; Tassonyi E
    Arzneimittelforschung; 1981; 31(6):1013-5. PubMed ID: 6266429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K; Kárpáti E
    Arzneimittelforschung; 1981; 31(11):1918-24. PubMed ID: 6172135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graded continuous administration of arduan during surgery with prolonged hypothermic perfusion].
    Sud'in VI; Lagutina AI; Suddason Ch
    Anesteziol Reanimatol; 1983; (6):5-8. PubMed ID: 6322619
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the neuromuscular blocking effect of Arduan.
    Tassonyi E
    Ther Hung; 1983; 31(1):13-7. PubMed ID: 6100820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.